Pharmacovigilance Global Market Report 2022: Rising Number of ADRs and Associated Consumer Hazards to Propel Growth – ResearchAndMarkets.com

Pharmacovigilance Global Market Report 2022: Rising Number of ADRs and Associated Consumer Hazards to Propel Growth – ResearchAndMarkets.com




Pharmacovigilance Global Market Report 2022: Rising Number of ADRs and Associated Consumer Hazards to Propel Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pharmacovigilance Market Analysis by Type of Methods, by Type of Service, by Drug Development, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.

The rising number of ADRs and associated consumer hazards, the growing elderly population, and the usage of drugs have increased globally as chronic illnesses including diabetes, cardiovascular, oncological, and respiratory ailments have become more common are some of the primary market drivers.

However, internet-based medicine information and the lack of available competent personnel are expected to restrain the market growth.

Regional Markets

In 2021, North America had the greatest share of the market due to growing spending by key stakeholders on the development of innovative drugs, the growing rate of drug addiction and adverse drug responses is a primary cause of illness and mortality, and the existence of major manufacturers of pharmaceuticals and medical equipment. However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to the increasing investments and encouraging government programs to satisfy the needs of the populace, raising patient consciousness, the accessibility of different outsourcing companies, and increased output, reduced costs, and sharing of resources.

Segmentation: Pharmacovigilance market Analysis Report 2021-2029

Type of Methods (Revenue, USD Million)

  • Cohort Event Monitoring
  • Intensified ADR Reporting
  • EHR Mining
  • Targeted Spontaneous Reporting
  • Spontaneous Reporting

Type of Service (Revenue, USD Million)

  • Contract Outsourcing
  • In-house

Drug Development (Revenue, USD Million)

  • Preclinical Studies
  • Phase I
  • Phase II
  • Phase III
  • Phase IV or Post Marketing Surveillance

By Region (Revenue, USD Million)

North America

  • U.S
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Key Topics Covered:

1. Research Methodology

2. Introduction: Pharmacovigilance

3. Executive Summary

4. Market Dynamics

5. Market Environment Analysis

6. COVID-19 Impact Analysis: Pharmacovigilance Market

7. Market Analysis by Type of Methods

8. Market Analysis by Type of Service

9. Market Analysis by Drug Development

10. Regional Market Analysis

11. North America Pharmacovigilance Market

12. Europe Pharmacovigilance Market

13. Asia Pacific Pharmacovigilance Market

14. Latin America Pharmacovigilance Market

15. MEA Pharmacovigilance Market

16. Competitor Analysis

17. Company Profiles

18. Conclusion

19. Recommendations

Companies Mentioned

  • Accenture (Ireland)
  • ArisGlobal (US)
  • Capgemini (France)
  • Cognizant (US)
  • FMD K&L (US)
  • IBM Corporation (US)
  • ICON plc. (Ireland)
  • IQVIA (US)
  • ITClinical (Portugal)
  • Laboratory Corporation of America Holdings (US)
  • Linical Accelovance (US)
  • PAREXEL International Corporation (US)
  • TAKE Solutions Ltd. (India)
  • Wipro Ltd. (India).

For more information about this report visit https://www.researchandmarkets.com/r/ikazwd

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900